Chong Kun Dang Pharmaceutical

This study compares two different anti-rejection medications (RaparoBell® and My-Rept®) for kidney transplant patients who are already taking standard maintenance therapy. Researchers want to see which drug works better and is safer when patients switch to it. The trial involves …